跳至主要内容
临床试验/IRCT20100524004010N28
IRCT20100524004010N28已完成未知

The effect of low FODMAP (Fermentable, Oligo-, Di-, Mono-saccharides and Polyols) diet with glutamine supplement versus placebo on clinical outcomes, quality of life and intestinal permeability in patients with irritable bowel syndrome

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Patients with irritable bowel syndrome, according to a gastroenterologist diagnosed according to ROME IV criteria (having at least one day a week over the past 3 months for at least two of the following: 1- related to Defecation; 2- related to the frequency of defecation, 3- related to changes in stool shape and consistency, and no pathological findings in gastrointestinal
  • Body Mass Index in range (18-25)
  • Lack of any organic intestinal disease ( diagnosed by last 5 years ago colonoscopy) and intestinal infection (diagnosed by stool culture)
  • Lack of medical history of chronic gastrointestinal and colorectal disease
  • Lack of any major bowel surgery
  • Lack of medical history of liver disorders
  • Absence of regular use of laxatives or antidiarrheal drugs
  • No chronic use of corticosteroids and immunosuppressants
  • No usage of drugs that modifying the digestive motility such as metoclopramide, cisapride, diphenoxylate
  • No usage of drugs that increased bleeding of intestinal mucosa such as aspirin, warfarin and heparin
  • Absence of nicotine and its derivatives use in the last 6 months
  • No usage of NSAIDs and aspirin in last week (influence on gut permeability)
  • Absence of severe mental or behavioral disorder
  • Lack of medical history of kidney disorders

排除标准

  • Not agree to entering the study
  • Consumption of artificial sweeteners (effect on intestinal permeability) 2 days before entering the study

研究者

相似试验